Login / Signup

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.

Emi TakashitaNoriko KinoshitaSeiya YamayoshiYuko Sakai-TagawaSeiichiro FujisakiMutsumi ItoKiyoko Iwatsuki-HorimotoPeter HalfmannShinji WatanabeKenji MaedaMasaki ImaiHiroaki MitsuyaNorio OhmagariMakoto TakedaHideki HasegawaYoshihiro Kawaoka
Published in: The New England journal of medicine (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus